# OnCo record nxc-201-car-t (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/nxc-201-car-t/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "nxc-201-car-t" ;
  schema:name "NXC-201 CAR-T"@en ;
  schema:alternateName "HBI0101 CAR-T"@en ;
  schema:description "NXC-201 CAR-T is an experimental CAR-T cell therapy from Nexcella in phase 2 trials, aimed at BCMA."@en ;
  schema:url <https://onco.cc/drugs/nxc-201-car-t/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.3324/haematol.2022.281628>, <https://clinicaltrials.gov/study/NCT04720313>, <https://clinicaltrials.gov/search?intr=NXC-201>, <https://www.nexcella.com> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "CAR-T cell therapy" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/bcma/> ;
  onco:companies <https://onco.cc/companies/immix-biopharma/> ;
  onco:trials <https://onco.cc/trials/nxc-201-mm/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nxc-201-hbi0101-asherie-haematologica-2023/> .